• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Bladder cancer: twenty years of progress and the challenges that remain.

作者信息

Lamm D L

出版信息

CA Cancer J Clin. 1998 Sep-Oct;48(5):263-8. doi: 10.3322/canjclin.48.5.263.

DOI:10.3322/canjclin.48.5.263
PMID:9742893
Abstract

The most obvious improvements in the care of patients with bladder cancer over the past 20 years are bacille Calmette-Guérin immunotherapy for superficial bladder cancer and cisplatin and methotrexate-based combination chemotherapy for advanced disease. The challenges that remain are prevention, early detection, and improved treatment of both superficial and advanced disease. Meeting these challenges requires research, financial investment, and public education.

摘要

相似文献

1
Bladder cancer: twenty years of progress and the challenges that remain.
CA Cancer J Clin. 1998 Sep-Oct;48(5):263-8. doi: 10.3322/canjclin.48.5.263.
2
Efficacy and safety of bacille Calmette-Guérin immunotherapy in superficial bladder cancer.卡介苗免疫疗法在浅表性膀胱癌中的疗效与安全性
Clin Infect Dis. 2000 Sep;31 Suppl 3:S86-90. doi: 10.1086/314064.
3
Tolerability of bacille Calmette-Guérin maintenance therapy for superficial bladder cancer.
Urology. 2001 May;57(5):883-8. doi: 10.1016/s0090-4295(00)01117-1.
4
Purified Protein Derivative Skin test prior to bacillus Calmette-Guérin Therapy May have Therapeutic Impact in Patients with Nonmuscle Invasive Bladder Cancer.卡介苗治疗前纯化蛋白衍生物皮肤试验可能对非肌肉浸润性膀胱癌患者有治疗作用。
J Urol. 2018 Jun;199(6):1446-1451. doi: 10.1016/j.juro.2017.12.057. Epub 2018 Jan 4.
5
The influence of intravesical therapy on progression of superficial transitional cell carcinoma of the bladder. A metaanalytic comparison of chemotherapy versus bacilli Calmette-Guerin immunotherapy.膀胱内治疗对膀胱浅表性移行细胞癌进展的影响。化疗与卡介苗免疫疗法的荟萃分析比较。
J Urol. 2005 Nov;174(5):1783-4. doi: 10.1016/s0022-5347(01)68779-2.
6
The Timing of Radical Cystectomy for bacillus Calmette-Guérin Failure: Comparison of Outcomes and Risk Factors for Prognosis.卡介苗失败后根治性膀胱切除术的时机：结局比较和预后危险因素分析。
J Urol. 2016 Jun;195(6):1704-9. doi: 10.1016/j.juro.2016.01.087. Epub 2016 Jan 22.
7
Urothelial bladder biopsy--important evolution prognosis factor of superficial bladder cancer under intravesical Bacille Calmette-Guérin therapy.
Rom J Morphol Embryol. 1991 Jan-Jun;37(1-2):61-8.
8
Bladder cancer.膀胱癌
Curr Opin Oncol. 2007 May;19(3):241-7. doi: 10.1097/CCO.0b013e3280ad43ac.
9
Bacillus Calmette-Guerin versus doxorubicin versus thiotepa: a randomized prospective study in 202 patients with superficial bladder cancer.卡介苗与多柔比星与噻替派：202例浅表性膀胱癌患者的随机前瞻性研究
J Urol. 1990 Mar;143(3):502-6. doi: 10.1016/s0022-5347(17)40002-4.
10
Importance of urinary interleukin-18 in intravesical immunotherapy with bacillus calmette-guérin for superficial bladder tumors.尿白细胞介素-18在卡介苗膀胱内免疫治疗浅表性膀胱肿瘤中的重要性。
Urol Int. 2005;75(2):114-8. doi: 10.1159/000087163.

引用本文的文献

1
IL-12 minicircle delivery via extracellular vesicles as immunotherapy for bladder cancer.通过细胞外囊泡递送白细胞介素-12作为膀胱癌的免疫疗法。
Cell Prolif. 2025 Jan;58(1):e13739. doi: 10.1111/cpr.13739. Epub 2024 Aug 28.
2
Treatment of nonmuscle invading bladder cancer: do physicians in the United States practice evidence based medicine? The use and economic implications of intravesical chemotherapy after transurethral resection of bladder tumors.非肌层浸润性膀胱癌的治疗：美国医生是否践行循证医学？经尿道膀胱肿瘤切除术后膀胱内化疗的应用及经济影响。
Cancer. 2009 Jun 15;115(12):2660-70. doi: 10.1002/cncr.24311.
3
Metallothionein isoform 3 as a potential biomarker for human bladder cancer.
Environ Health Perspect. 2000 May;108(5):413-8. doi: 10.1289/ehp.00108413.